From “positive trends in survival” to “completely eradicated,” the results from a phase III cancer trial has oncologists and patients in the UK excited. An innovative combination of two immunotherapy drugs were shown to extend the life of patients with metastatic or relapsed head and neck cancer without forcing them to endure extreme chemotherapy.
Around […]The post Immunotherapy Drugs So Effective that Tumors Disappear in Weeks for Head and Neck Cancer Patients in Landmark Trial appeared first on Good News Network.
